A federal jury in Grand Rapids, Mich., found the Zimmer willfully infringed on patents for devices that use pulsing liquid to clean bones during joint replacement surgery, according to the report.
Stryker’s claim called out the Zimmer Pulsavac products, which made $386 million in sales last year.
Zimmer plans to appeal the verdict.
More Articles on Supply Chain:
Victrex Looks for Market Growth in 2013
CareFusion Files 2012 Fiscal Form, $3.6B FY Revenue Reported
Former Synthes Chair Donates $2M to Establish Orthopedic Endowment
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
